Suppr超能文献

阿育吠陀和悉达疗法干预对慢性淋巴细胞白血病的治疗效果:一例报告

Effect of Ayurveda and Siddha interventions in the management of chronic lymphocytic leukemia: A case report.

作者信息

Prajapati Abhay Kumar, Venate Parvathy, Monika T, Huddar V G

机构信息

Department of Kayachikitsa, All India Institute of Ayurveda, New Delhi, 110076, India.

National Institute of Siddha Chennai, Tamil Nadu, 600047, India.

出版信息

J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101017. doi: 10.1016/j.jaim.2024.101017. Epub 2024 Dec 14.

Abstract

Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by the clonal proliferation of the mature, yet dysfunctional B lymphocytes in blood and its subsequent infiltration of the marrow, lymphoid tissues and spleen. The resultant immune dysfunction exposes the body to multiple infections and is a cause of major mortality. Here, we discuss the case of a 46-year-old male suffering from CLL who presented with long-standing episodes of low-grade fever, productive cough and throat irritation, lethargy and pedal edema. He was treatment-naïve at the time of presentation. He was treated in lines of Rajayakshma as per Ayurveda, and Kuruthiputru as per Siddha medicine. After three years of treatment with continued follow up till date, comprising of Shamana Chikitsa (Ayurveda and Siddha internal medications), Sodhana (bio purificatory methods)through Mridu Virechana (therapeutic purgation) using Trivrut Avaleha 35g, Guduchi Rasayana (Tinospora cordifolia) and Yashtimadhu Rasayana(Glycyrrhiza glabra), patient reported reduction in frequency of infections, improved performance score with a mean reduction in TLC counts by 100 thousand/cu. mm in 10 months starting intervention. Presently the patient is stable with occasional episodes of dry cough and generalized weakness. Integrated practices involving Ayurveda and Siddha medicines may be beneficial to patients suffering from CLL by reducing the episodes of infections, improving the quality of life while pacifying the deranged hematological parameters to certain extent.

摘要

慢性淋巴细胞白血病(CLL)是一种血液系统恶性肿瘤,其特征是血液中成熟但功能失调的B淋巴细胞发生克隆性增殖,并随后浸润骨髓、淋巴组织和脾脏。由此产生的免疫功能障碍使身体易受多种感染,是主要的死亡原因。在此,我们讨论一例46岁男性慢性淋巴细胞白血病患者的病例,该患者长期出现低热、咳痰、咽喉不适、乏力和足部水肿。就诊时他尚未接受过治疗。他按照阿育吠陀医学接受了拉贾亚克什玛疗法,按照悉达医学接受了库鲁提普特鲁疗法。经过三年的治疗并持续随访至今,包括使用35克特里武特阿瓦莱哈进行温和的泻下疗法、古杜奇药油(匙羹藤)和雅什蒂马杜药油(光果甘草)进行沙马纳疗法(阿育吠陀和悉达医学的内服药)、索德哈纳疗法(生物净化方法),患者报告感染频率降低,体能评分改善,从干预开始的10个月内白细胞计数平均减少10万/立方毫米。目前患者病情稳定,偶尔出现干咳和全身无力。涉及阿育吠陀和悉达医学的综合疗法可能对慢性淋巴细胞白血病患者有益,可减少感染发作,提高生活质量,同时在一定程度上使紊乱的血液学参数恢复正常。

相似文献

1
Effect of Ayurveda and Siddha interventions in the management of chronic lymphocytic leukemia: A case report.
J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101017. doi: 10.1016/j.jaim.2024.101017. Epub 2024 Dec 14.
2
AYUSH (Indian System of Medicines) Therapeutics for COVID-19: A Living Systematic Review and Meta-Analysis (First Update).
J Integr Complement Med. 2023 Mar;29(3):139-155. doi: 10.1089/jicm.2022.0559. Epub 2022 Nov 2.
3
Ayush [Indian System of Medicines] Prophylaxis Against COVID-19: A Living Systematic Review and Meta-Analysis (Second Update).
J Integr Complement Med. 2024 Jul;30(7):602-619. doi: 10.1089/jicm.2023.0357. Epub 2024 Feb 29.
4
Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100658. doi: 10.1016/j.jaim.2022.100658. Epub 2022 Nov 16.
5
Ayurveda panchakarma treatment success in a case of chronic spontaneous urticaria non-responding to conventional medicine-A case study.
J Ayurveda Integr Med. 2022 Apr-Jun;13(2):100549. doi: 10.1016/j.jaim.2022.100549. Epub 2022 Mar 4.
8
An Ayurveda approach in the management of avascular necrosis of bilateral hip joint-A case report.
J Ayurveda Integr Med. 2023 Sep-Oct;14(5):100792. doi: 10.1016/j.jaim.2023.100792. Epub 2023 Sep 21.
9
Exploring scientific validation of Triphala Rasayana in ayurveda as a source of rejuvenation for contemporary healthcare: An update.
J Ethnopharmacol. 2021 Jun 12;273:113829. doi: 10.1016/j.jep.2021.113829. Epub 2021 Jan 17.
10
Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites.
Curr Oncol. 2022 Sep 22;29(10):6787-6793. doi: 10.3390/curroncol29100534.

本文引用的文献

1
Antioxidant and Anticancer Activity of Extracts in Breast Cell Lines.
Life (Basel). 2024 Feb 6;14(2):228. doi: 10.3390/life14020228.
2
Chronic lymphocytic leukemia treatment algorithm 2022.
Blood Cancer J. 2022 Nov 29;12(11):161. doi: 10.1038/s41408-022-00756-9.
5
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.
7
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
8
The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice.
BMC Complement Altern Med. 2017 Dec 15;17(1):536. doi: 10.1186/s12906-017-2030-7.
9
Treatment of Hematological Malignancies with Glycyrrhizic Acid.
Anticancer Res. 2017 Mar;37(3):997-1004. doi: 10.21873/anticanres.11409.
10
Chronic lymphocytic leukaemia.
Nat Rev Dis Primers. 2017 Jan 19;3:16096. doi: 10.1038/nrdp.2016.96.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验